Page last updated: 2024-09-03

rmi 12330a and guanosine triphosphate

rmi 12330a has been researched along with guanosine triphosphate in 2 studies

Compound Research Comparison

Studies
(rmi 12330a)
Trials
(rmi 12330a)
Recent Studies (post-2010)
(rmi 12330a)
Studies
(guanosine triphosphate)
Trials
(guanosine triphosphate)
Recent Studies (post-2010) (guanosine triphosphate)
14102414,728252,115

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belardetti, F; Biondi, C; Caputo, A; Portolan, A1
Becq-Giraudon, L; Goursaud, S; Gressens, P; Janet, T; Muller, JM; Pineau, N1

Other Studies

2 other study(ies) available for rmi 12330a and guanosine triphosphate

ArticleYear
[Preliminary studies on the characterization of adenylate cyclase from segmental ganglia of the leech Hirudo medicinalis].
    Bollettino della Societa italiana di biologia sperimentale, 1981, Jun-15, Volume: 57, Issue:11

    Topics: Adenosine Triphosphate; Adenylyl Cyclases; Animals; Dose-Response Relationship, Drug; Ganglia; Guanosine Triphosphate; Heterocyclic Compounds; Imines; Leeches; Methysergide; Serotonin

1981
Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Journal of neuroimmunology, 2005, Volume: 158, Issue:1-2

    Topics: Adenine; Adenylyl Cyclase Inhibitors; Analysis of Variance; Blotting, Southern; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Humans; Imines; Iodine Isotopes; Lymphoma; Peptide Fragments; Peptide PHI; Pertussis Toxin; Protein Binding; Radioligand Assay; Receptors, Cell Surface; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasoactive Intestinal Peptide, Type II; Receptors, Vasoactive Intestinal Polypeptide, Type I; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Vasoactive Intestinal Peptide

2005